Status:
RECRUITING
Clinical and Molecular Correlates of Response to First Line Treatment in Lichen Planus
Lead Sponsor:
University of Aberdeen
Conditions:
Lichen Planus, Oral
Lichen Planus of Vulva
Eligibility:
All Genders
18+ years
Brief Summary
Lichen planus is a common inflammatory (swelling and pain of tissue) disease in the general population that affects mostly the mouth although skin and genital areas can also be affected. It can cause ...
Detailed Description
PARTICIPANT SELECTION AND ENROLMENT IDENTIFYING PARTICIPANTS All participants will be selected from attendants of the Oral \& Maxillofacial Unit, Women's Day Clinic and Aberdeen Dental School in the ...
Eligibility Criteria
Inclusion
- Patients aged more than 18 years, with confirmed histopathological diagnosis of lichen planus and undergoing topical steroid therapy.
- Participants who have the capacity to consent.
- Participants who show a willingness to attend an initial appointment and a follow-up post-treatment appointment.
Exclusion
- Patients on systemic steroids and other immunosuppressive agents for the treatment of lichen planus
- Cases of graft versus host disease or those suffering from other systemic inflammatory conditions mimicking lichen planus (e.g. connective tissue disease).
- Pregnant and lactating participants.
- Inability to consent.
Key Trial Info
Start Date :
February 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05330572
Start Date
February 7 2022
End Date
September 30 2026
Last Update
April 10 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Aberdeen
Aberdeen, Aberdeen, Scotland, United Kingdom, AB24 3FX
2
Aberdeen Dental School
Aberdeen, United Kingdom, AB25 2ZR